Opinion|Videos|August 2, 2024
Patient Burden Associated with Pneumococcal Disease
A medical professional examines the significant patient burden imposed by pneumococcal infections, highlighting how this burden drove the development of innovative vaccine technologies.
Advertisement
Episodes in this series
- Discuss the patient burden of pneumococcal infections that led to the development of novel vaccines.
Advertisement
Related to this article
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
2
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
3
Survodutide Shows Cardiovascular Safety in SYNCHRONIZE-CVOT
4
How Pharmacists Help Patients Spot Patterns in Glucose Readings
5